These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 7884892)
21. Defective HIV-1 quasispecies in the form of multiply drug-resistant proviral DNA within cells can be rescued by superinfection with different subtype variants of HIV-1 and by HIV-2 and SIV. Quan Y; Xu H; Wainberg MA J Antimicrob Chemother; 2014 Jan; 69(1):21-7. PubMed ID: 23963235 [TBL] [Abstract][Full Text] [Related]
22. Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection. Petry H; Dittmer U; Stahl-Hennig C; Coulibaly C; Makoschey B; Fuchs D; Wachter H; Tolle T; Morys-Wortmann C; Kaup FJ J Virol; 1995 Mar; 69(3):1564-74. PubMed ID: 7853490 [TBL] [Abstract][Full Text] [Related]
23. Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1. Zachar V; Spire B; Hirsch I; Chermann JC; Ebbesen P J Virol; 1991 Apr; 65(4):2102-7. PubMed ID: 1705998 [TBL] [Abstract][Full Text] [Related]
24. HIV Provirus Stably Reproduces Parental Latent and Induced Transcription Phenotypes Regardless of the Chromosomal Integration Site. Hashemi FB; Barreto K; Bernhard W; Hashemi P; Lomness A; Sadowski I J Virol; 2016 Jun; 90(11):5302-14. PubMed ID: 26984732 [TBL] [Abstract][Full Text] [Related]
25. Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1. Moriuchi H; Moriuchi M; Arthos J; Hoxie J; Fauci AS J Virol; 1997 Dec; 71(12):9664-71. PubMed ID: 9371631 [TBL] [Abstract][Full Text] [Related]
26. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells. Macías D; Oya R; Saniger L; Martín F; Luque F Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078 [TBL] [Abstract][Full Text] [Related]
27. Productive expression state confers resistance of human immunodeficiency virus (HIV)-2-infected lymphoma cells against superinfection by HIV-1. von Dalnok GK; Kleinschmidt A; Neumann M; Leib-Moesch C; Erfle V; Brack-Werner R Arch Virol; 1993; 131(3-4):419-29. PubMed ID: 8347081 [TBL] [Abstract][Full Text] [Related]
28. HIV-1 integration landscape during latent and active infection. Cohn LB; Silva IT; Oliveira TY; Rosales RA; Parrish EH; Learn GH; Hahn BH; Czartoski JL; McElrath MJ; Lehmann C; Klein F; Caskey M; Walker BD; Siliciano JD; Siliciano RF; Jankovic M; Nussenzweig MC Cell; 2015 Jan; 160(3):420-32. PubMed ID: 25635456 [TBL] [Abstract][Full Text] [Related]
29. Syphilis superinfection activates expression of human immunodeficiency virus I in latently infected rabbits. Tseng CK; Hughes MA; Hsu PL; Mahoney S; Duvic M; Sell S Am J Pathol; 1991 May; 138(5):1149-64. PubMed ID: 1850960 [TBL] [Abstract][Full Text] [Related]
30. Electronmicroscopic study of human herpesvirus 6-infected human T cell lines superinfected with human immunodeficiency virus type 1. Takasaki T; Ohkawa N; Sano K; Morimatsu S; Nakano T; Nakai M; Yamaguchi J; Kurane I Acta Virol; 1997 Aug; 41(4):221-9. PubMed ID: 9391653 [TBL] [Abstract][Full Text] [Related]
31. A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells. Shahabuddin M; Bentsman G; Volsky B; Rodriguez I; Volsky DJ J Virol; 1996 Nov; 70(11):7992-8002. PubMed ID: 8892923 [TBL] [Abstract][Full Text] [Related]
32. Modeling HIV-1 Latency Using Primary CD4 Takata H; Kessing C; Sy A; Lima N; Sciumbata J; Mori L; Jones RB; Chomont N; Michael NL; Valente S; Trautmann L J Virol; 2019 Jun; 93(11):. PubMed ID: 30918072 [TBL] [Abstract][Full Text] [Related]
33. Human immunodeficiency virus type 1 (HIV-1) superinfection of a cell clone converting it from production of defective to infectious HIV-1 is mediated predominantly by CD4 regions other than the major binding site for HIV-1 glycoproteins. Ohki K; Kishi M; Ohmura K; Morikawa Y; Jones IM; Azuma I; Ikuta K J Gen Virol; 1992 Jul; 73 ( Pt 7)():1761-72. PubMed ID: 1629701 [TBL] [Abstract][Full Text] [Related]
34. Homologous interference resulting from the presence of defective particles of human immunodeficiency virus type 1. Bernier R; Tremblay M J Virol; 1995 Jan; 69(1):291-300. PubMed ID: 7983721 [TBL] [Abstract][Full Text] [Related]
35. Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants. Dedera D; Ratner L J Virol; 1991 Nov; 65(11):6129-36. PubMed ID: 1717715 [TBL] [Abstract][Full Text] [Related]
36. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. Zhu T; Muthui D; Holte S; Nickle D; Feng F; Brodie S; Hwangbo Y; Mullins JI; Corey L J Virol; 2002 Jan; 76(2):707-16. PubMed ID: 11752161 [TBL] [Abstract][Full Text] [Related]
37. Differences in Activation of HIV-1 Replication by Superinfection With HIV-1 and HIV-2 in U1 Cells. Wang X; Sun B; Mbondji C; Biswas S; Zhao J; Hewlett I J Cell Physiol; 2017 Jul; 232(7):1746-1753. PubMed ID: 27662631 [TBL] [Abstract][Full Text] [Related]
38. Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein. Paik SY; Banerjea AC; Harmison GG; Chen CJ; Schubert M J Virol; 1995 Jun; 69(6):3529-37. PubMed ID: 7745700 [TBL] [Abstract][Full Text] [Related]
39. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane. Wang Z; Gurule EE; Brennan TP; Gerold JM; Kwon KJ; Hosmane NN; Kumar MR; Beg SA; Capoferri AA; Ray SC; Ho YC; Hill AL; Siliciano JD; Siliciano RF Proc Natl Acad Sci U S A; 2018 Mar; 115(11):E2575-E2584. PubMed ID: 29483265 [TBL] [Abstract][Full Text] [Related]
40. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences. Li XD; Moore B; Cloyd MW Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]